For people with auditory impairment, hearing aid use could slow metabolic decline in regions of the brain associated with cognitive function.

The Australian radiopharma firm's financial maneuver comes amid its roll out of the first targeted positron emission tomography agent for kidney cancer. 

Demand is growing for the modality, but provider groups, particularly those in private practice, have struggled to meet state regulatory requirements. 

Experts recently uncovered strong associations between reports of memory loss from patients' peers/loved ones and the presence of tau tangles on imaging.

If approved, the kit could allow for more flexible production of prostate cancer imaging agents.

An AI-aided way has emerged to confidently select dementia patients who are likely to benefit from amyloid-PET imaging while appropriately de-selecting patients for whom the costly exam would probably be unhelpful.  

Up to 30% of patients have metastatic disease by the time they are initially diagnosed with renal cell carcinoma, making accurate staging a critical element of treatment planning. 

The Indianapolis-based drugmaker can hit the hefty total by reaching certain clinical, regulatory and commercial milestones.